ABEONA THERAPEUTICS INC. Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Abeona Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Abeona Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.8M, a 15.9% increase year-over-year.
  • Abeona Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.19M, a 51.4% increase year-over-year.
  • Abeona Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.77M, a 56.3% increase from 2022.
  • Abeona Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.05M, a 65.8% decline from 2021.
  • Abeona Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.92M, a 52.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.77M +$1.72M +56.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $3.05M -$5.87M -65.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $8.92M +$3.06M +52.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $5.85M -$1.49M -20.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $7.34M -$840K -10.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 $8.18M +$3.53M +76.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $4.64M -$185K -3.83% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $4.83M +$461K +10.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $4.37M +$3.06M +235% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $1.31M +$866K +197% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $439K +$49K +12.6% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $390K -$676K -63.4% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 $1.07M Jan 1, 2011 Dec 31, 2011 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.